The Journal of clinical investigationDec 9, 2014

Prostaglandin signals reduce helpful immune cell activity in Alzheimer's disease models

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Apr 1, 2026

Abstract

Microglia-specific deletion of the PGE2 receptor EP2 restores beneficial functions in Alzheimer's disease models.

Microglia play essential roles in maintaining neural function by clearing misfolded proteins and regulating inflammation.
In Alzheimer's disease, microglial functions become impaired, leading to increased synaptic and neuronal loss.
The COX/PGE2 pathway is associated with the development of Alzheimer's disease in both human studies and rodent models.
Deleting the EP2 receptor in microglia improves their ability to migrate towards and clear Aβ peptides.
Suppression of toxic inflammation and enhancement of protective insulin-like growth factor 1 signaling occurs with EP2 deletion.
Restoration of these microglial functions may help prevent synaptic injury and memory deficits in Alzheimer's disease.

Simplified

Microglia, the innate immune cells of the CNS, perform critical inflammatory and noninflammatory functions that maintain normal neural function. For example, microglia clear misfolded proteins, elaborate trophic factors, and regulate and terminate toxic inflammation. In Alzheimer's disease (AD), however, beneficial microglial functions become impaired, accelerating synaptic and neuronal loss. Better understanding of the molecular mechanisms that contribute to microglial dysfunction is an important objective for identifying potential strategies to delay progression to AD. The inflammatory cyclooxygenase/prostaglandin E2 (COX/PGE2) pathway has been implicated in preclinical AD development, both in human epidemiology studies and in transgenic rodent models of AD. Here, we evaluated murine models that recapitulate microglial responses to Aβ peptides and determined that microglia-specific deletion of the gene encoding the PGE2 receptor EP2 restores microglial chemotaxis and Aβ clearance, suppresses toxic inflammation, increases cytoprotective insulin-like growth factor 1 (IGF1) signaling, and prevents synaptic injury and memory deficits. Our findings indicate that EP2 signaling suppresses beneficial microglia functions that falter during AD development and suggest that inhibition of the COX/PGE2/EP2 immune pathway has potential as a strategy to restore healthy microglial function and prevent progression to AD.

Full Text

Full text is available at the source.

View Full Text ↗

Prostaglandin signals reduce helpful immune cell activity in Alzheimer's disease models

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief